Elanco Animal Health Incorporated (ETR:5EA)
Germany · Delayed Price · Currency is EUR 20.06
0.00 (0.00%)
Inactive · Last trade price on Mar 16, 2026
Elanco Animal Health Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Market Capitalization | 10,829 | 9,577 | 5,782 | 6,643 | 5,422 | 11,806 |
Market Cap Growth | 117.42% | 65.61% | -12.95% | 22.51% | -54.07% | -0.22% |
Enterprise Value | 14,211 | 12,829 | 9,518 | 11,655 | 10,511 | 16,998 |
Last Close Price | 20.05 | 19.46 | 19.20 | 19.20 | 19.20 | 24.80 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 17.71 | - | - | - |
PS Ratio | 2.70 | 2.38 | 1.35 | 1.66 | 1.31 | 2.82 |
PB Ratio | 1.94 | 1.72 | 0.98 | 1.18 | 0.80 | 1.79 |
P/FCF Ratio | 44.77 | 39.59 | 15.19 | 56.05 | 20.62 | 41.44 |
P/OCF Ratio | 22.70 | 20.08 | 11.07 | 27.10 | 12.82 | 27.80 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.48 | 3.20 | 2.22 | 2.92 | 2.55 | 4.06 |
EV/EBITDA Ratio | 16.71 | 16.59 | 11.21 | 13.27 | 11.16 | 18.59 |
EV/EBIT Ratio | 63.28 | 58.16 | 38.34 | 38.92 | 28.80 | 51.41 |
EV/FCF Ratio | 58.75 | 53.04 | 25.01 | 98.34 | 39.97 | 59.67 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.64 | 0.68 | 0.73 | 0.95 | 0.82 | 0.86 |
Debt / EBITDA Ratio | 3.92 | 4.53 | 4.76 | 5.81 | 5.65 | 5.96 |
Debt / FCF Ratio | 11.17 | 15.65 | 11.28 | 45.16 | 21.27 | 20.00 |
Net Debt / Equity Ratio | 0.56 | 0.60 | 0.65 | 0.89 | 0.77 | 0.78 |
Net Debt / EBITDA Ratio | 3.68 | 4.30 | 4.52 | 5.73 | 5.59 | 5.62 |
Net Debt / FCF Ratio | 9.77 | 13.73 | 10.09 | 42.47 | 20.05 | 18.03 |
Asset Turnover | 0.37 | 0.36 | 0.33 | 0.30 | 0.28 | 0.28 |
Inventory Turnover | 1.30 | 1.28 | 1.21 | 1.18 | 1.32 | 1.40 |
Quick Ratio | 0.91 | 1.00 | 1.12 | 1.22 | 0.90 | 1.09 |
Current Ratio | 2.05 | 2.17 | 2.44 | 2.75 | 1.93 | 1.99 |
Return on Equity (ROE) | -2.98% | -3.67% | 5.49% | -18.22% | -1.05% | -6.04% |
Return on Assets (ROA) | 1.56% | 1.25% | 1.19% | 1.39% | 1.52% | 1.38% |
Return on Invested Capital (ROIC) | 3.29% | 2.52% | 1.63% | 2.68% | 2.97% | 2.71% |
Return on Capital Employed (ROCE) | 2.90% | 2.20% | 2.30% | 2.50% | 2.80% | 2.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -1.82% | -2.06% | 5.65% | -16.77% | -1.35% | -3.60% |
FCF Yield | 2.23% | 2.53% | 6.58% | 1.78% | 4.85% | 2.41% |
Buyback Yield / Dilution | 0.18% | 0.18% | -1.02% | -0.82% | -0.23% | -10.38% |